NASDAQ:RNTX | Profit Breakdown | Rein Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$0.00-$6.08M-$6.38M
2026-03-31$0.00-$5.23M-$5.84M
2025-12-31$0.00-$32.66M-$31.97M
2025-09-30$0.00-$5.49M-$5.58M
2025-06-30$0.00-$6.87M-$6.82M
2025-03-31$0.00-$5.61M-$5.5M
2024-12-31$0.00-$42.8M-$40.98M
2024-09-30$0.00-$6.07M-$5.85M
2024-06-30$0.00-$9.04M-$8.94M
2024-03-31$0.00-$7.21M-$7.11M
2023-12-31$0.00-$7.29M-$7.34M
2023-09-30$0.00-$1.98M-$1.83M
2023-06-30$0.00-$1.99M-$1.79M
2023-03-31$0.00-$5.01M-$4.78M
2022-12-31$0.00-$4.7M-$4.55M
2022-09-30$0.00-$6.48M-$6.37M
2022-06-30$0.00-$8.04M-$7.99M
2022-03-31$0.00-$8.42M-$8.42M
2021-12-31$0.00-$6.82M-$6.8M
2021-09-30$0.00-$6.79M-$6.7M
2021-06-30$0.00-$6.01M-$5.69M
2021-03-31$0.00-$6.99M-$6.98M
2020-12-31$0.00-$4.19M-$11.17M
2020-09-30$0.00-$5.03M-$5.02M
2020-06-30$0.00-$4.4M-$4.39M
2020-03-31$0.00-$6.88M-$6.75M
2019-12-31$0.00-$7.35M-$7.24M
2019-09-30$0.00-$7.92M-$7.75M
2019-06-30$0.00-$7.38M-$7.17M
2019-03-31$0.00-$7.31M-$7.21M
2018-12-31$0.00-$6.98M-$7.03M
2018-09-30$0.00-$7.5M-$7.43M
2018-06-30$0.00-$9.66M-$9.49M
2018-03-31$0.00-$7.76M-$7.59M
2017-12-31$0.00-$7.04M-$6.87M
2017-09-30$0.00-$6.43M-$6.26M
2017-06-30$0.00-$4.95M-$4.92M
2017-03-31$0.00-$4.59M-$4.56M
2016-12-31$0.00-$4.45M-$4.44M
2016-09-30$0.00-$4.23M-$4.22M
2016-06-30$0.00-$5.55M-$5.53M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$50.63M-$49.87M
2024-12-31$0.00-$65.11M-$62.88M
2023-12-31$0.00-$16.28M-$15.73M
2022-12-31$0.00-$27.65M-$27.33M
2021-12-31$0.00-$26.61M-$26.16M
2020-12-31$0.00-$20.5M-$27.33M
2019-12-31$0.00-$29.96M-$29.37M
2018-12-31$0.00-$31.9M-$31.55M
2017-12-31$0.00-$23.01M-$22.6M
2016-12-31$0.00-$18.17M-$18.12M
2015-12-31$0.00-$12.89M-$12.88M